NCT00160082View on ClinicalTrials.gov

Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

May 31, 2003

Conditions
Post Polio Syndrome, PPS
Interventions
DRUG

Xepol

Trial Locations (4)

Unknown

Danderyd Hospital, Danderyd

Sahlgrenska University Hospital, Gothenburg

Uppsala Academic Hospital, Uppsala

SE-141 86

Huddinge University Hospital, Stockholm

Sponsors
All Listed Sponsors
lead

Calliditas Therapeutics AB

INDUSTRY